Connection
Paul Buehler to Lipoproteins, LDL
This is a "connection" page, showing publications Paul Buehler has written about Lipoproteins, LDL.
|
|
Connection Strength |
|
 |
|
 |
|
0.026 |
|
|
|
-
Lipiski M, Deuel JW, Baek JH, Engelsberger WR, Buehler PW, Schaer DJ. Human Hp1-1 and Hp2-2 phenotype-specific haptoglobin therapeutics are both effective in vitro and in guinea pigs to attenuate hemoglobin toxicity. Antioxid Redox Signal. 2013 Nov 10; 19(14):1619-33.
Score: 0.026